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ABSTRACT 
 
Ceylan Cakit: The Structure of Mammalian Telomeres Associated with the Shelterin 
Subcomplexes 
(Under the direction of Dr. Jack D. Griffith) 
 
 
Telomeres are the specialized DNA-protein complexes at eukaryotic chromosome ends.  
They are essential to protect linear chromosome ends from nucleolytic attack and chromosomal end-
to-end fusions, which may lead to chromosomal abnormalities. Genomic instability, a hallmark for 
both cancer and aging, is majorly induced by chromosomal abnormalities. Therefore, telomere 
length and structure are equally important for the maintenance of genomic stability. Mammalian 
telomeres associate with a six-subunit, telomere-specific shelterin complex, as well as shelterin 
subcomplexes. In this study, I will visualize the structure of mammalian telomeres associated with 
the shelterin subcomplexes using electron microscopy (EM). In order to achieve this goal, I will 
examine the association of model telomeres with single-stranded and double-stranded telomeric 
DNA repeat binding proteins separately. This study will be extremely valuable for understanding the 
mechanistic details of the regulation of mammalian telomere structure and function by the shelterin 
complex subunits and subcomplexes. 
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CHAPTER 1 
 
MAMMALIAN TELOMERES AND THE SHELTERIN COMPLEX 
 
 
 
1.1. Telomeres and Genomic Stability 
Throughout the lifetime of every cell and organism, proper maintenance of DNA 
represents the major challenge. Genomic instability is one of the primary reasons for both 
cancer and ageing. Protection of genetic material in eukaryotes becomes much more complex 
due the linear nature of chromosomes. Telomeres are the specialized DNA-protein structures 
at the ends of linear eukaryotic chromosomes. These structures enable cells to recognize 
natural and broken chromosome ends as distinct structures (1). Therefore, telomeres serve an 
essential function by protecting chromosome ends from degradation, terminal fusions, and 
inappropriate repair activities. Functional telomeres are not recognized and processed as 
double strand breaks (2, 3), whereas telomere dysfunction caused by either the loss of 
telomeric DNA or telomere protection activates DNA damage response pathways (4, 5, 6). 
The characteristics of telomere dysfunction in mammalian cells can be outlined as telomeric 
DNA degradation and cell cycle arrest accompanied by chromosomal fusions and genomic 
instability (7, 8). As a consequence, genomic stability relies on the proper maintenance of 
telomere structure and function.  Therefore, the long-term goal of this study is to elucidate 
  2 
  
  
telomere structure and its regulation by telomere-specific proteins. 
In mammalian telomeres, which are the focus of this study, the DNA component is 
made up of tandem repeats of double stranded TTAGGG that terminate in a 150-200-
nucleotide long single-stranded G-rich strand 3’ overhang (7, 8, 9). Telomeric DNA folds 
into a “telomere loop (t-loop)” structure, where the G-rich 3’ single-stranded overhang 
invades the duplex telomeric tract (Figure 1.1). T-loops were first discovered via 
visualization of purified mammalian telomeric DNA using electron microscopy (9). To date, 
telomeres of many organisms including humans, mice, chickens, plants, yeast and ciliates 
have also been shown to form t-loops (9, 10, 11, 12). It is not known whether the t-loop is the 
most common structure of natural chromosome ends, or if it is the structures of all 
chromosome ends in vivo (8, 16). However, many studies revealed that the proper protection 
and regulation of telomeric structures are central to the suppression of the cell cycle 
checkpoint activation at natural chromosome ends (4, 13, 14, 15). Therefore, structural 
folding of telomeric DNA into t-loops may be a required conformational change for the 
inhibition of an inappropriate DNA damage response. Alternatively, t-loop structure may be 
regulatory for limiting the accessibility of chromosome ends to the telomere-interacting 
factors such as telomerase (8, 16).  
 
1.2. Maintenance of Telomere Length 
The average telomere length in human cells is within a range of 5-15 kb and becomes 
shorter by 150-200 base pair with every successful DNA replication, since the very end of  
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Figure 1.1: Structure of DNA in a telomere loop (t-loop).  A) Schematic of DNA structure in 
a telomere loop (t-loop) (16). Red line indicates the G-rich telomeric repeat sequence, while 
black line indicates C-rich telomeric repeat sequence.  B)  Electron micrograph of telomeric 
DNA isolated from HeLa subclone 1.2.11 in a t-loop conformation (9). 
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the lagging strand cannot be replicated by DNA polymerases, referred to as the “end-
replication problem” (17, 18, 19). As a consequence, telomeres reach a critical length after 
about 50 cell divisions (Hayflick limit), where normal somatic cells stop dividing and 
permanently arrest, a phenomenon called “replicative senescence” (20). This gradual decline 
in telomere length sets a limit to the lifespan of normal somatic cells. Therefore, telomeres 
act as the biological clock of a cell (19). 
In contrast to normal somatic cells, the majority of cancer cells circumvents 
“replicative senescence”, and become immortal by expressing telomerase. Telomerase is a 
unique eukaryotic reverse transcriptase and is responsible for adding telomeric repeats to the 
3’ G-rich overhang of DNA at telomeres using its own RNA subunit as a template (21, 22). 
Telomerase expression is not a general feature of normal somatic cells. Most cancer cells 
turn on telomerase expression, whereas some telomerase deficient cancer cells use 
“Alternative Lengthening of Telomeres” (ALT) (23, 24) for immortalization. ALT cells 
depend on homologous recombination for telomere length maintenance (23, 24, 25, 26); the 
exact mechanistic details of this pathway are still being investigated. However, highly 
heterogeneous telomeres in length ranging in between 2-20 kb in humans and free telomeric 
circles (t-circles) are markers for ALT cells (25, 26, 27). Alternatively, both telomerase 
expression and ALT pathway activation may be operational simultaneously for some cancer 
types or under certain circumstances in order to maintain telomere length (28).  
 
1.3. Shelterin Complex 
Telomeres are known to associate with telomere-specific proteins as well as with 
many repair and recombination proteins. In humans, shelterin is a telomere-specific, multi-
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protein complex, which interacts with chromosome ends throughout the cell cycle. It has six 
subunits: Trf1, Trf2, hRap1, Tin2, Tpp1, and Pot1 (Figure 1.2) (16, 29). The proposed 
functions of the shelterin complex at the telomeres include the protection of telomeric DNA 
protection and the regulation of telomere accessibility (16). In any case, the dynamic 
interactions of shelterin complex with telomeres, as well as the dynamic interactions within 
the shelterin complex subunits, are central for telomere structure and function. However, the 
molecular details of these interactions are still unknown. Therefore, the objective of this 
study is to elucidate the structure of mammalian telomeres associated with the shelterin 
complex and to understand telomere structure regulation by the shelterin complex. I 
hypothesize that shelterin complexes formed by different combinations of shelterin subunits 
will regulate telomere function by inducing structural alterations in telomere structure. 
The shelterin complex specifically interacts with telomeric DNA, since the shelterin 
subunits; Trf1, Trf2 and Pot1 have the ability to recognize and bind to TTAGGG repeats. 
Trf1 and Trf2 interact with double-stranded TTAGGG repeats through their single myb-like 
DNA binding domain at their carboxyl-terminus (30). Single base-alterations in TTAGGG 
repeat sequences are sufficient to diminish the association of Trf1 and Trf2 with telomeres 
(31, 32). Furthermore, binding of Trf1 and Trf2 to telomeres as homodimers (33), or as 
higher order oligomers, increases the level of specificity, so that only a tandem array of 
TTAGGG repeats becomes the DNA target. As a consequence, shelterin can distinguish 
isolated occurances of TTAGGG repeats in the rest of the genome. Similarly, Pot1 
recognizes and binds specifically to the single-stranded 3’-end and internal 5’-
TAGGGTTAG-3’ sequences via its N-terminal DNA binding domain (34, 35). Taken as a 
whole, the highly specific association of Trf1, Trf2, and Pot1 with TTAGGG repeats forms  
  6 
  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Schematic of the shelterin complex on mammalian telomeric DNA. Pot1 binds to 
the 3’-end single-stranded TTAGGG repeats. Tpp1 is the only Pot1-interacting subunit. The 
interaction within the shelterin complex is bridged by the interaction between Tpp1 and Tin2. 
Tin2 binds to both Trf1 and Trf2, which recognize and bind to double-stranded TTAGGG 
repeats. hRap1 only binds to Trf2 in the complex. As shown in the figure, Tpp1, Tin2, and 
hRap1 do not directly associate with TTAGGG DNA repeats (16). 
 
 
 
 
  7 
  
  
the scaffold for the loading the other three subunits of the shelterin complex: Tin2, Tpp1, and 
hRap1 (16). 
Trf1 is a “negative regulator” of telomere length. Trf1 overexpression results in 
gradual decrease in telomere length, while Trf1 inhibition results in telomere elongation (36).  
Equally important Trf2 also plays role in telomere length regulation and it is essential for 
telomere protection. Trf2 overexpression protects even the critically short telomeres, whereas 
Trf2 inhibition results in total telomere protection loss followed by terminal fusions (6, 37). 
Recently, Trf2 has been suggested to have a role in telomere replication, where the 
replication is challenging due to its repetitive nature of telomeric DNA (38, 39). 
Pot1, being the only single-stranded TTAGGG repeat binding protein, is the most 
conserved subunit of the shelterin complex (16, 35, 40). Pot1 inhibition leads to increased 
telomere length in telomerase positive cells, indicating that single-strand 3’overhang 
becomes accessible to telomerase in the absence of Pot1 (41).  On the contrary, a recent 
report suggests a role for Pot1 and its interaction partner Tpp1 in telomerase progression 
(42). On the other hand, another recent study reveals mammalian Pot1’s requirement for 
Tpp1 for its telomere safeguarding function (43). In agreement with this, Tpp1 [Ptop (44), 
Pip1 (45) and Tint1 (46)] have already been shown to have an effect on Pot1’s localization to 
telomeres (44, 45). 
Within the shelterin complex, the single-stranded 3’overhang region of the telomeric 
DNA is linked to the duplex telomeric tract by the interaction of Tpp1 to Tin2 (47). Tin2 was 
first identified as Trf1-interacting protein (48). However, subsequent studies revealed the 
association of Tin2 with Trf2 and its role in Trf2 function and stabilization on telomeres (49, 
50). Tin2 can bind to both Trf1 and Trf2 at the same time (50). The Trf1-Tin2 interaction is 
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mediated by TRF homology domain (TRFH) of Trf1, while Trf2-Tin2 interaction is outside 
the TRFH domain of Trf2 (51). Lastly, hRap1 was discovered as a Trf2-interacting factor. It 
localizes to the telomeres by associating with Trf2 through the C-terminus (52). It has been 
indicated to have a role in telomere length regulation as well (52, 53, 54).  
Throughout these aforementioned studies, shelterin subcomplexes associated with 
telomeres have also been detected (29, 50). These subcomplexes may have different 
biological functions. Therefore, characterization of both these subcomplexes and the shelterin 
complex as a whole, in terms of their localization on telomeres, copy number, composition 
and biological roles, are equally important for discovering the exact mechanistic details of 
telomere structure and function regulation, as well as telomere maintenance. 
 
1.4. DNA Remodeling Activities of Shelterin Subunits and Subcomplexes 
Telomeres may be protected and regulated by the shelterin complex subunits through 
DNA remodeling activities of either individual shelterin subunits, subcomplexes, or the 
whole shelterin complex. This possibility is partly supported by the induction of senescence 
with Trf2 overexpression in the absence of telomeric DNA loss (6). Further evidence reveals 
that Trf2, which is not a helicase, facilitates t-loop formation by itself on telomeric substrates 
in vitro (9). This reaction is not efficient. Only 15-20% of the model telomere substrates form 
t-loop structures in the presence of Trf2 (55). Therefore, the synergistic action of shelterin 
subunits altogether, or in different combinations may be required for efficient DNA 
remodeling and subsequent structural folding into t-loop. Therefore, in Specific Aim 1 of 
this study, I will test the binding and DNA remodeling activities of human Pot1 alone, 
and human Tpp1-Pot1 fusion protein on model telomeres using electron microscopy 
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(EM). In order to achieve this goal, I will purify Pot1, Tpp1 and Tpp1-Pot1 proteins and 
visualize their interaction with telomeric DNA substrates using EM. I will verify these 
interactions by gel retardation assays. This study will indicate whether single-stranded 
TTAGGG repeat binding protein, Pot1, has the ability to affect telomere function by 
inducing structural changes in telomeric DNA structure on its own, or in association with 
Tpp1. 
Alternatively, binding of Trf1, Trf2, hRap1, and Tin2 to double-stranded TTAGGG 
repeats can remodel telomeric DNA, facilitate, or inhibit t-loop generation. Therefore, in 
Specific Aim 2, I will test the binding and DNA remodeling activities of shelterin 
subcomplexes; (1) Trf2, hRap1 and (2) Trf2, hRap1, Tin2 on model telomeres using 
electron microscopy. Since N-terminal-[His]6-tagged human Trf2, hRap1, and Tin2 proteins 
are readily available in our laboratory, I will assemble the aforementioned complexes on 
model telomere substrates, visualize protein-DNA complexes using EM, and verify 
interactions by gel retardation assays. This study will reveal whether the DNA remodeling 
activity of the double-stranded TTAGGG repeat binding protein, Trf2, will be facilitated, or 
inhibited by its interaction partners: hRap1, and Tin2. 
Understanding the function of telomeres and the shelterin complex relies on 
elucidating the structure of telomeres and telomere bound shelterin complex subunits. Once 
completed, the structural information of the shelterin subunits and subcomplexes bound to 
model telomeres will be a powerful tool for further insights into the mechanisms responsible 
for the telomere structure regulation during aging and oncogenesis. Furthermore, this study 
will also be of great value for identification of possible therapeutic targets of anti-aging and 
anti-cancer therapies. 
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1.5. Preliminary Data and Progress Report 
 
1.5.1. Progress on Specific Aim 1: I will test the binding and DNA remodeling activities 
of human Pot1 alone, and human Tpp1-Pot1 fusion protein on telomeric DNA using 
electron microscopy (EM).  
For the accomplishment of this aim, I have successfully constructed N-terminal-[His]6-
tagged human Pot1 (hPot1) vector by subcloning PCR-amplified hPot1 cDNA into 
mammalian expression vector pcDNA4B (Invitrogen) using BamHI and EcoRV restriction 
sites. I have also constructed N-terminally-[His]6-tagged human Tpp1-Pot1 (hTpp1-hPot1) 
vector by inserting PCR-amplified hPot1 cDNA in frame to the C-terminus of human Tpp1 
(hTpp1) cDNA using NotI and XbaI restriction sites after subcloning PCR-amplified hTpp1 
cDNA into insect vector pFastBacHTA (Invitrogen) using BamHI and EcoRI restriction 
sites. Each subcloning was tested by restriction enzyme digestion and verified by sequencing 
constructed recombinant vectors. In addition, I generated and purified bacmid DNA with 
hTpp1-hPot1 fusion protein coding sequences using Bac-to-Bac system (Invitrogen). I have 
analyzed bacmid DNA using standard PCR reaction with M13 forward and reverse primers. 
 
1.6. Research Design and Methods 
 
1.6.1. Rationale 
In vitro, Trf2 can facilitate t-loop formation by itself on telomeric substrates (9) and it 
localizes specifically to ss-ds junction in the t-loop structure. This reaction does not require 
any ATP, and is not efficient (55). Therefore, the synergistic action of other shelterin 
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complex subunits may be required for efficient telomeric DNA remodeling. In order to test 
this, experimental techniques, which will be used for both Specific Aim 1 and Specific Aim 2 
of this study, will be the same. However, the interaction of different subunits and 
subcomplexes with model telomeres will be tested. For Specific Aim1, I will focus on the 
single-stranded telomeric repeat binding proteins (hPot1, and hTpp1), while I will focus on 
the double-stranded telomeric repeat binding proteins (hTrf2, hRap1, and hTin2) for Specific 
Aim 2. Furthermore, I will pay particular attention to the localization of the aforementioned 
proteins, and subcomplexes on model telomeres.  
 
1.6.2. Materials and Methods 
 
1.6.2.1. Generation of hPot1 and hTpp1-hPot1 expression vectors. Standard PCR 
reactions were carried out to amplify hPot1 and hTpp1 cDNAs. An N-terminal- [His]6-tagged 
hPot1 vector was constructed by subcloning amplified hPot1 cDNA into pcDNA4B 
(Invitrogen). N-terminally-[His]6-tagged Tpp1-hPot1 was constructed by inserting hPot1 
cDNA in frame to the C-terminus of Tpp1 after subcloning of human Tpp1 cDNA into insect 
vector pFastBacHTA (Invitrogen). Subcloning was tested by restriction enzyme digestion 
and verified by sequencing constructed recombinant vectors. 
 
1.6.2.2. Recombinant hPot1 and hTpp1-hPot1 fusion protein expression. In vitro 
expression of recombinant hPot1 will be tested using TNT Coupled Transcription/Translation 
System (Promega) according to manifecturer’s guide. The expression will be determined by 
Western blotting with monoclonal mouse His-tag-antibody (Qiagen). Small scale hPot1 
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expression in vivo will be tested and optimized by transfecting human 293A embryonic 
kidney cells using Fugene (Roche) transfection reagent in a 6-well culture dish according to 
manifecturer’s procedures. For large scale protein expression, 293A embryonic kidney cells 
grown as adherent cultures in 10% FBS (Sigma) containing Dulbecco’s Modified Eagle 
Medium with high glucose (Gibco) will be transfected with hPot1 mammalian expression 
vector using calcium phosphate transfection method as described in (56). After 48 hours 
further incubation at 37oC incubator containing a humidified atmosphere of 5% CO2, cells 
will be harvested by centrifugation at 2000 rpm for 10 min at 4oC. The cell pellet will be 
washed once with ice cold 1X PBS, frozen and kept at -80oC until further use.  
In order to express hTpp1-hPot1 fusion protein, bacmid DNA with hTpp1-hPot1 
coding sequences purified will be used to transfect Sf21 (Invitrogen) in a 6-well culture dish 
using Cellfectin (Invitrogen). P1 viral stock will be ready after 72h incubation at 27oC. P2 
viral stock will be generated according to manufacturer’s guidelines (Invitrogen). For large 
scale expression of the hTpp1-hPot1 fusion protein, 100 ml of Sf21 cells grown in 
suspension in Grace’s Media (GibcoSFM) will be inoculated with virus at MOI = 10. After 
48 hours further incubation at 27oC, cells will be collected by spinning at 2000 rpm for 10 
min at 4oC, and protein expression will be tested by Western blotting with monoclonal mouse 
His-antibody (Qiagen). The cell pellet will be washed once with ice cold 1X PBS, frozen and 
kept at -80oC until further use.  
 
1.6.2.3. Recombinant hPot1 and hTpp1-hPot1 fusion protein purification. Both N-
terminal-[His]6-tagged hPot1 and N-terminal-[His]6-tagged hTpp1-hPot1 fusion protein will 
be purified using TalonTM metal affinity resin (Clontech, Palo Alto, CA) as previously 
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described (38). SDS-PAGE and Coomassie blue staining will be used to analyze the purity of 
the proteins. 
1.6.2.4. Recombinant hTrf2, hRap1, and hTin2 expression vectors. N-terminal-[His]6-
tagged insect expression vectors have already been constructed in our laboratory by cloning 
human Trf2, hRap1, and Tin2 encoding cDNAs into pFastBacHT (Invitrogen) after tagging 
them with six-histidine using PCR. 
1.6.2.5. Recombinant hTrf1, hTrf2, hRap1, and hTin2 purification. N-terminal-[His]6-
tagged hTrf1, hTrf2, hRap1, and hTin2 were already purified using TalonTM metal affinity 
resin (Clontech, Palo Alto, CA) as previously described (38). The purity of each protein was 
analyzed by SDS-PAGE and Coomassie blue staining. 
 
1.6.2.6. Generation of Telomeric DNA Templates. Model telomere substrates will be 
generated as previously described (55). Briefly, pRST5 plasmid with ~3kb of non-telomeric 
DNA and a 500 bp region of telomeric repeat will be linearized using BbsI and BsmI 
restriction sites. This restriction digestion will locate 500 bp telomeric repeat tracts to one 
end of the linearized molecule. A 54-nt single stranded (TTAGGG)6 overhang telomeric 
repeat tract will be generated by ligating a 58-nt oligonucleotide onto the 3’ telomeric end 
(Figure 1.3). Different telomeric substrates will be generated using 3’overhang in different 
length, or sequence. Substrates with altered single-stranded double strand junction sequences 
will also be generated (55). 
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1.6.2.7. Electron Microscopy. Model telomere templates will be incubated with 100 ng of 
each protein for 30 min in EM buffer (20 mM HEPES (pH 7.5), 0.1 mM EDTA, 0.5 mM 
dithiothreitol, 100 mM KCl) on ice. Protein-DNA complexes will be fixed with 0.6% 
glutaraldehyde and fractionated using a 2.5 ml BioGel A15M column. The complexes will be 
incubated with spermidine just before directly adsorbed to glow charged carbon foil grids, 
dehydrated by water and ethanol washes and rotary shadow cast with tungsten. Electron 
micrographs will be taken using an FEI Tecnai 12 Electron Microscope and Gatan Ultrascan 
US400SP digital camera with Gatan Digital Micrograph software (9, 58). 
 
1.6.2.8. Gel retardation Assays. Proteins will be incubated with the aforementioned model 
substrates labeled with 32P in EM buffer for 20 min at room temperature. Then, the mixtures 
will be directly loaded onto a 3.5% (w/v) nondenaturing polyacrylamide gel in 45mM Tris 
borate, 1mM EDTA. The gels will be run at 140 V for 1 h at 4 °C, dried, analyzed by 
autoradiography, and quantified using a Storm 840 PhosphorImager (GE Healthcare) (38). 
 
1.6.3. Expected Results 
 
1.6.3.1. Expected Results for Specific Aim 1 
Pot1 is known to recognize and bind specifically to single-stranded 3’-end and internal 5’-
(T)TAGGGTTAG-3’ sequences via its DNA binding domain (34, 35). Tpp1 does not directly 
bind to telomeric DNA; it associates with Pot1. Therefore, hPot1 and hTpp1-hPot1 fusion 
protein will associate with single-stranded 3’overhang, whereas hTpp1 alone will not be able 
to bind to model telomeres. I expect to see diminished interaction of hPot1, and hTpp1-hPot1  
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Figure 1.3: Schematic of model telomere substrates (adapted from Stansel, RM, et.al., 2001.) 
pRST5 plasmid with 3kb of non- telomeric DNA and a 500 bp region of telomeric repeat will 
be linearized using denoted restriction sites. 500 bp telomeric repeat tracts will be positioned 
at one end of the linearized molecule. A 54-nt single stranded (TTAGGG)6 overhang 
telomeric repeat tract of the same length will be generated by ligation of a 58-nt 
oligonucleotide onto the 3’ telomeric end.  Different telomeric substrates will be generated 
using 3’overhang in different length and sequence. Substrates with altered single-stranded 
double stranded junction sequences will also be generated (55). 
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with altered 3’- TTAGGG repeat sequence containing templates. I will also be able to score 
these proteins according to their localization on model substrates. A protein can interact with 
non-telomeric DNA, telomeric double-stranded (ds) DNA, telomeric single-stranded (ss) 
DNA, or to ss-ds DNA junction of the telomeric substrates in this experimental system. 
pRST5 plasmid without any TTAGGG repeat sequences will be used as a negative control. 
hTpp1 protein alone will be another negative control for these experiments due to its inability 
to associate with telomeric TTAGGG sequences on its own. Telomeric DNA substrates 
without proteins, proteins without telomeric DNA substrates will also be used as the negative 
controls for this study.  BSA, which cannot bind to DNA, will also be a negative control. 
hTrf2 can be used as a positive control for DNA remodeling under the same experimental 
conditions, since it has already been shown to facilitate t-loop formation on its own in vitro. 
Similarly, p53 can also be a positive control, since it is known to bind to 3’overhangs and ss-
ds junctions without any sequence preference (57). Any requirement for ATP or reaction 
buffer of different composition (ion, salt, etc.) will also be tested.   
 
1.6.3.2. Expected Results for Specific Aim 2 
For this aim, I will test the binding and DNA remodeling activities of (1) Trf2, 
hRap1, and (2) Trf2, hRap1, Tin2 subcomplexes on model telomere substrates. I expect to 
see t-loop formations upon the interaction of Trf2 with model telomeres (55), if the purified 
Trf2 protein is active. Since hRap1, and Tin2 cannot directly interact with TTAGGG 
sequences, the effect of these proteins on telomeric DNA remodeling can be tested in two 
ways. Firstly, either hRap1, or Tin2 can be incubated simultaneously with Trf2, and then 
with model DNA. Alternatively, Trf2-hRap1, Trf2-Tin2, hRap1-Tin2 or Trf2-hRap1-Tin2 
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can be pre-incubated before their interaction with DNA substrates. This will reveal whether 
hRap1, Tin2, or hRap1 with Tin2 has an effect on binding and DNA remodeling activities of 
Trf2. Secondly, order of addition experiments can be carried out in order to test whether 
there is a preferred sequence of protein-protein interactions for efficient telomeric DNA 
remodeling. In addition, localization of these shelterin subunits and subcomplexes on model 
telomeres will also be scored. Similar to Specific Aim 1, pRST5 plasmid without any 
TTAGGG repeat sequence, hRap1, and Tin2 proteins alone, telomeric DNA substrates 
without proteins, proteins without telomeric DNA substrates, and BSA will be the negative 
controls. p53 will be used as positive control for binding to ss-ds junctions (57). For testing 
the possible role of hRap1, or Tin2 in facilitation/inhibiton of t-loop formation, hTrf2 will be 
the positive control. Any requirement for ATP or reaction buffer of different composition 
(ion, salt, etc.) will also be tested.  
 
1.6.4. Potential Pitfalls 
 
1.6.4.1. Potential Pitfalls for Specific Aim 1 
It may not be possible to express N-terminal-[His]6-tagged hTpp1-hPot1 fusion 
protein from insect cells. Even if expressed, the fusion protein may insoluble and cannot be 
purified. In this case, position of the His-tag and the relative position of the cDNA sequences 
encoding these two proteins will be switched in the insect. Alternatively, a mammalian 
expression system for hTpp1-hPot1 can be generated. Even if purified successfully, the 
fusion protein may not be active due to the restricted three-dimensional diffusion of the 
protein. Another trial of cloning, expression, and purification can be employed by the 
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addition of a linker region in between these two proteins during cloning step. In any case, we 
have already purified Tf1-Pot1 fusion (58), chicken Pot1 (cPot1), and hTpp1 proteins in our 
laboratory.  cPot1 has 61% sequence identity to hPot1 and DNA binding domains of cPot1, 
and hPot1 are 75% identical (59). Alternatively, individually purified hTpp1 and hPot1, or 
hTpp1 and chicken Pot1 proteins can be tested for their binding and DNA remodeling 
activities in trans, instead of in cis.  
 
1.6.4.2. Potential Pitfalls for Specific Aim 2 
hTrf2, hRap1, and hTin2 are readily available in our laboratory. EM analysis and gel 
retardation assays will be carried to make sure that these proteins are biologically active. For 
instance, Trf2 should be interacting with double-stranded TTAGGG repeats, if it is active. If 
the interactions of these proteins are cell-cycle regulated, and requires additional proteins, it 
is possible to co-express them in vivo and purify these subcomplexes from insect cells. On 
the other hand, protein expression in insect cells may be a problem, if these proteins require 
posttranslational modification(s), which occurs only in mammalian but not insect cells, for 
interacting with each other and, interacting with DNA, or for their biological function. This 
may also be a potential problem for Specific Aim 1. Under such circumstances, it is possible 
to construct mammalian expression vectors for these proteins, and test their expression in 
mammalian cells. 
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1.6.5. Summary and Future Directions 
Telomeres are extremely important due to the role they play in both cancer and aging. 
Their proper maintenance and regulation are central to the protection of genomic stability 
and viability of the cell. The recent discovery of t-loops by use of electron microscopy has 
provided very significant information on the structural folding of the DNA component of 
telomeres. However, the exact structure of telomeres is still unknown. Therefore, 
understanding telomere structure will be of great value for the discovery of the mechanisms 
responsible for telomere function regulation. In this process, the structure of telomere-
specific factors and structures generated upon their binding to telomeres are equally of great 
value.  
Therefore, I aim to test the DNA binding and remodeling activities of the shelterin 
complex subunits and subcomplexes in this study.  I will focus on the activities of single-
stranded and double-stranded TTAGGG repeat binding proteins, separately. In the 
continuation of this study, the next will be the examination of binding and DNA remodeling 
activities of Trf1 containing subcomplexes, and the whole shelterin complex. In the long 
term, the structural information provided by the characterization of the whole shelterin 
complex in terms of exact localization and copy number of subunits bound to telomeres, will 
be a milestone in telomere biology. 
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